COPD Trial, Recruiting NCT06201403 Sponsor: Istanbul Medipol University Hospital Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06201403
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with COPD:

  • People who have been diagnosed with Group C or D COPD based on the GOLD staging system (a standard system doctors use to classify how severe COPD is)
  • People who have been taking the same COPD medications without any changes for at least the past 4 weeks
  • People who do not have any additional conditions affecting the bones and joints, nervous system, or heart

For healthy participants:

  • People who are over 18 years of age
  • People who have not been diagnosed with any chronic (long-term) illness
  • People who do not smoke

Who may not be able to join:

  • People who have a lung or breathing condition other than COPD
  • People who have had a sudden worsening of their COPD symptoms (called an exacerbation) within the last 4 weeks
  • People whose COPD symptoms worsen significantly during the study itself
  • People who have a layer of fatty tissue at the specific body areas where measurements will be taken, as this could affect the accuracy of results
  • People who have taken part in another clinical trial within the last 30 days that could influence this study's results

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 09050585279

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istanbul Medipol University Hospital
Registry
ClinicalTrials.gov
Start date
20 January 2024
Est. completion
15 January 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

M.Sternocleidomastoideus (SCM) myotonometric measurement; M. Trapezius myotonometric measurement; M. Biceps brachii myotonometric measurement; M. Pectoralis Major (PM) myotonometric measurement; M. Rectus abdominis (RA) myotonometric measurement; M.Rectus femoris myotonometric measurement; M.Vastus lateralis myotonometric measurement; M. Tibialis anterior myotonometric measurement

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov